Biliary cholesterol secretion: more than a simple ABC - PubMed (original) (raw)

Review

Biliary cholesterol secretion: more than a simple ABC

Arne Dikkers et al. World J Gastroenterol. 2010.

Abstract

Biliary cholesterol secretion is a process important for 2 major disease complexes, atherosclerotic cardiovascular disease and cholesterol gallstone disease. With respect to cardiovascular disease, biliary cholesterol secretion is regarded as the final step for the elimination of cholesterol originating from cholesterol-laden macrophage foam cells in the vessel wall in a pathway named reverse cholesterol transport. On the other hand, cholesterol hypersecretion into the bile is considered the main pathophysiological determinant of cholesterol gallstone formation. This review summarizes current knowledge on the origins of cholesterol secreted into the bile as well as the relevant processes and transporters involved. Next to the established ATP-binding cassette (ABC) transporters mediating the biliary secretion of bile acids (ABCB11), phospholipids (ABCB4) and cholesterol (ABCG5/G8), special attention is given to emerging proteins that modulate or mediate biliary cholesterol secretion. In this regard, the potential impact of the phosphatidylserine flippase ATPase class I type 8B member 1, the Niemann Pick C1-like protein 1 that mediates cholesterol absorption and the high density lipoprotein cholesterol uptake receptor, scavenger receptor class B type I, is discussed.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Overview of hepatic cholesterol metabolism in relation to biliary sterol secrection. HDL: High-density lipoprotein; BA: Bile acid; LDLR: Low-density lipoprotein receptor; LRP: LDLR-related protein; NTCP: Na+ taurocholate co-transporting peptide; OATP: Organic anion transport polypeptides; SR-BI: Scavenger receptor class B type I; (V)LDL: (Very) low-density lipoprotein.

Figure 2

Figure 2

Overview of canalicular transporters/proteins that are involved in biliary bile acid, cholesterol and phospholipid secretion. ABC: ATP-binding cassette transporter; ATP8B1: ATPase class I type 8B member 1; SR-BI: Scavenger receptor class B type I; NPC1L1: Niemann-Pick C1-like protein 1.

References

    1. Cohen DE. Lipoprotein metabolism and cholesterol balance. In: The liver: biology and pathobiology., editor. 5th ed. Chichester, West Sussex, UK; Hoboken, NJ: John Wiley and Sons; 2009.
    1. Ginsberg HN, Fisher EA. The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism. J Lipid Res. 2009;50 Suppl:S162–S166. - PMC - PubMed
    1. Adiels M, Olofsson SO, Taskinen MR, Borén J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:1225–1236. - PubMed
    1. Lewis GF. Determinants of plasma HDL concentrations and reverse cholesterol transport. Curr Opin Cardiol. 2006;21:345–352. - PubMed
    1. Angelin B, Parini P, Eriksson M. Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL. Atheroscler Suppl. 2002;3:23–30. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources